Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,674 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.
Ronacher K, Chegou NN, Kleynhans L, Djoba Siawaya JF, du Plessis N, Loxton AG, Maasdorp E, Tromp G, Kidd M, Stanley K, Kriel M, Menezes A, Gutschmidt A, van der Spuy GD, Warren RM, Dietze R, Okwera A, Thiel B, Belisle JT, Cliff JM, Boom WH, Johnson JL, van Helden PD, Dockrell HM, Walzl G. Ronacher K, et al. Among authors: johnson jl. Tuberculosis (Edinb). 2019 Sep;118:101859. doi: 10.1016/j.tube.2019.101859. Epub 2019 Aug 12. Tuberculosis (Edinb). 2019. PMID: 31434026 Free PMC article.
A metabolic biosignature of early response to anti-tuberculosis treatment.
Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT. Mahapatra S, et al. Among authors: johnson jl. BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53. BMC Infect Dis. 2014. PMID: 24484441 Free PMC article.
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.
Johnson JL, Hadad DJ, Dietze R, Maciel EL, Sewali B, Gitta P, Okwera A, Mugerwa RD, Alcaneses MR, Quelapio MI, Tupasi TE, Horter L, Debanne SM, Eisenach KD, Boom WH. Johnson JL, et al. Am J Respir Crit Care Med. 2009 Sep 15;180(6):558-63. doi: 10.1164/rccm.200904-0536OC. Epub 2009 Jun 19. Am J Respir Crit Care Med. 2009. PMID: 19542476 Free PMC article. Clinical Trial.
How we determined the most reliable solid medium for studying treatment of tuberculosis.
Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV. Heilig CM, et al. Among authors: johnson jl. Tuberculosis (Edinb). 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006. Epub 2014 Mar 4. Tuberculosis (Edinb). 2014. PMID: 24661816 Free PMC article.
Bacterial Factors That Predict Relapse after Tuberculosis Therapy.
Colangeli R, Jedrey H, Kim S, Connell R, Ma S, Chippada Venkata UD, Chakravorty S, Gupta A, Sizemore EE, Diem L, Sherman DR, Okwera A, Dietze R, Boom WH, Johnson JL, Mac Kenzie WR, Alland D; DMID 01-009/Tuberculosis Trials Consortium Study 22 Teams. Colangeli R, et al. Among authors: johnson jl. N Engl J Med. 2018 Aug 30;379(9):823-833. doi: 10.1056/NEJMoa1715849. N Engl J Med. 2018. PMID: 30157391 Free PMC article. Clinical Trial.
Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy.
Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT. Fitzgerald BL, et al. Among authors: johnson jl. ACS Infect Dis. 2019 Mar 8;5(3):353-364. doi: 10.1021/acsinfecdis.8b00241. Epub 2019 Jan 10. ACS Infect Dis. 2019. PMID: 30585483 Free PMC article. Clinical Trial.
Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.
Ribeiro-Rodrigues R, Resende Co T, Johnson JL, Ribeiro F, Palaci M, Sá RT, Maciel EL, Pereira Lima FE, Dettoni V, Toossi Z, Boom WH, Dietze R, Ellner JJ, Hirsch CS. Ribeiro-Rodrigues R, et al. Among authors: johnson jl. Clin Diagn Lab Immunol. 2002 Jul;9(4):818-23. doi: 10.1128/cdli.9.4.818-823.2002. Clin Diagn Lab Immunol. 2002. PMID: 12093679 Free PMC article.
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL. Furin JJ, et al. Among authors: johnson jl. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6591-6599. doi: 10.1128/AAC.01163-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550361 Free PMC article. Clinical Trial.
1,674 results